Functional Drug Targeting to Erythrocytes In Vivo using Antibody Bearing Liposome as Drug Vehicles

Show simple item record

dc.contributor.author Agrawal, Ajay K
dc.contributor.author Singhal, Arun
dc.contributor.author Gupta, C M
dc.date.accessioned 2008-03-26T07:36:42Z
dc.date.available 2008-03-26T07:36:42Z
dc.date.issued 1987
dc.identifier.citation Biochemical and Biophysical Research Communications (1987), 148, 357-361 en
dc.identifier.uri http://hdl.handle.net/123456789/123
dc.description.abstract Covalent attachment of anti-erythrocyte F(ab')2 to the liposome surface has recently been shown to considerably enhance tne liposome binding to erythrocytes in vivo. These antibody bearing liposomes have nPW been found quite effect1ve-as-vehicles for delivering the antimalarial drug., chloroquine. to erythrocytes in Plasmodium berghei-infected mice. This demonstrates the usefulness of antibody targeted liposomes as carriers for site-specific drug de1ivery. en
dc.format.extent 1390899 bytes
dc.format.mimetype application/pdf
dc.language.iso en en
dc.relation.ispartofseries CDRI Communication No. 4131 en
dc.title Functional Drug Targeting to Erythrocytes In Vivo using Antibody Bearing Liposome as Drug Vehicles en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account